Ashino Tissiane Eid Barbosa, Sant Ana Monielle Leal, Yoshikawa Ariane Harumi, Possebon Lucas, de Souza Costa Sara, Iyomasa-Pilon Melina Mizusaki, Souza Helena Ribeiro, Gonçalves Giovana Aparecida, Oliani Sonia Maria, Girol Ana Paula
São Paulo State University, (UNESP), Department of Biology, Laboratory of Immunomorphology, Cristovão Colombo Street, 2265, São José do Rio Preto, SP, Brazil; University Center Padre Albino (UNIFIPA), Estudantes Street, 225, Catanduva, SP, Brazil.
University Center Padre Albino (UNIFIPA), Estudantes Street, 225, Catanduva, SP, Brazil; Federal University of São Paulo (UNIFESP), Graduate Program in Structural and Functional Biology, Sena Madureira Street, 1500, São Paulo, SP, Brazil.
Int Immunopharmacol. 2021 Dec;101(Pt B):108285. doi: 10.1016/j.intimp.2021.108285. Epub 2021 Nov 19.
Benzopyrene is one of the main polycyclic aromatic hydrocarbons with carcinogenic capacity. Research has shown that anti-inflammatory drugs can reduce the incidence of lung cancer. In this scenario, we highlight piperlongumin (PL), an alkaloid from Piper longum with anti-inflammatory properties. Therefore, our aim was to study the effect of PL administration in a model of pulmonary carcinogenesis induced by benzopyrene in Balb/c mice. Animals were divided into 3 groups (n = 10/group): sham (10% DMSO), induced by benzopyrene (100 mg/kg, diluted in DMSO) without treatment (BaP) for 12 weeks and induced by benzopyrene and treated with PL (BaP/PL) (2 mg/kg in 10% DMSO) from the eighth week post-induction. Animals were weighed daily and pletsmography was performed in the 12th week. Genotoxicity and hemoglobin levels were analyzed in blood and quantification of leukocytes in bronchoalveolar lavage (BAL). Lungs were collected for histopathological evaluation, immunohistochemical studies of annexin A1 (AnxA1), cyclooxygenase 2 (COX-2), anti-apoptotic protein Bcl-2 and nuclear transcription factor (NF-kB) and also the measurement of interleukin cytokines (IL)-1β, IL-17 and tumor necrosis factor (TNF) -α. Treatment with PL reduced the pulmonary parameters (p < 0,001) of frequency, volume and pulmonary ventilation, decreased lymphocytes, monocytes and neutrophils in BAL (p < 0,05) as well as blood hemoglobin levels (p < 0,01). PL administration also reduced DNA damage and preserved the pulmonary architecture compared to the BaP group. Moreover, the anti-inflammatory effect of PL was evidenced by the maintenance of AnxA1 levels, reduction of COX-2 (p < 0,05), Bcl-2 (p < 0,01) and NF-kB (p < 0,001) expressions and decreased IL-1β, IL-17 (p < 0,01) and TNF-α (p < 0,05) levels. The results show the therapeutic potential of PL in the treatment of pulmonary anti-inflammatory and anti-tumor diseases with promising therapeutic implications.
苯并芘是具有致癌能力的主要多环芳烃之一。研究表明,抗炎药物可降低肺癌发病率。在这种情况下,我们重点介绍了荜茇明(PL),一种来自荜茇的具有抗炎特性的生物碱。因此,我们的目的是研究在Balb/c小鼠中,PL给药对苯并芘诱导的肺癌模型的影响。将动物分为3组(每组n = 10):假手术组(10%二甲基亚砜)、苯并芘诱导组(100 mg/kg,用二甲基亚砜稀释),未治疗12周(BaP组)以及苯并芘诱导组且从诱导后第8周开始用PL治疗(BaP/PL组)(2 mg/kg,溶于10%二甲基亚砜)。每天对动物称重,并在第12周进行体积描记法检测。分析血液中的遗传毒性和血红蛋白水平,并对支气管肺泡灌洗(BAL)中的白细胞进行定量分析。收集肺组织进行组织病理学评估、膜联蛋白A1(AnxA1)、环氧化酶2(COX-2)、抗凋亡蛋白Bcl-2和核转录因子(NF-kB)的免疫组织化学研究,以及白细胞介素细胞因子(IL)-1β、IL-17和肿瘤坏死因子(TNF)-α的检测。PL治疗降低了肺频率、肺容积和肺通气等肺参数(p < 0.001),减少了BAL中的淋巴细胞、单核细胞和中性粒细胞(p < 0.05)以及血液血红蛋白水平(p < 0.01)。与BaP组相比,PL给药还减少了DNA损伤并保留了肺结构。此外,PL的抗炎作用通过维持AnxA1水平、降低COX-2(p < 0.05)、Bcl-2(p < 0.01)和NF-kB(p < 0.001)表达以及降低IL-1β、IL-17(p < 0.01)和TNF-α(p < 0.05)水平得以证实。结果显示PL在治疗肺部抗炎和抗肿瘤疾病方面具有治疗潜力,具有良好的治疗意义。